Selected article for: "astrocytes IFN response and ifnÎb supernatant"
Author: Lindqvist, Richard; Mundt, Filip; Gilthorpe, Jonathan D.; Wölfel, Silke; Gekara, Nelson O.; Kröger, Andrea; Överby, Anna K.
Title: Fast type I interferon response protects astrocytes from flavivirus infection and virus-induced cytopathic effects
  • Document date: 2016_10_24
    • ID: 09tcnsxv_37
    Snippet: The antiviral effect of the supernatant was further investigated using qPCR as a more sensitive method of quantifying viral replication. Sixteen hours before TBEV infection, the cells were treated with either supernatant of 24-h TBEV-infected cells or IFNαB/D. The cells were infected with TBEV, and total RNA was extracted 48 hpi to detect TBEV RNA (Fig. 3g) . Pretreatment with supernatant of infected cells and 5000 U IFNαB/D had a similar inhib.....
    Document: The antiviral effect of the supernatant was further investigated using qPCR as a more sensitive method of quantifying viral replication. Sixteen hours before TBEV infection, the cells were treated with either supernatant of 24-h TBEV-infected cells or IFNαB/D. The cells were infected with TBEV, and total RNA was extracted 48 hpi to detect TBEV RNA (Fig. 3g) . Pretreatment with supernatant of infected cells and 5000 U IFNαB/D had a similar inhibitory effect on TBEV replication in WT astrocytes. However, no difference in viral replication was detected in IFNAR −/− astrocytes treated with or without supernatant, indicating a type I IFN-dependent antiviral effect. These results further suggest that the rapid type I IFN response is responsible for limiting viral infection and replication in astrocytes.

    Search related documents:
    Co phrase search for related documents
    • antiviral effect and infected cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • antiviral effect and infected cell supernatant: 1
    • antiviral effect and inhibitory effect: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • antiviral effect and replication viral infection: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • antiviral effect and supernatant antiviral effect: 1, 2
    • ifn response and infected cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • ifn response and inhibitory effect: 1, 2, 3, 4, 5, 6, 7, 8
    • ifn response and rapid type: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • ifn response and replication viral infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
    • infected cell and inhibitory effect: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • infected cell and rapid type: 1, 2
    • infected cell and replication viral infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • infected cell and sensitive method: 1, 2, 3, 4, 5, 6
    • infected cell and supernatant antiviral effect: 1
    • infected cell supernatant and sensitive method: 1
    • infected cell supernatant and supernatant antiviral effect: 1
    • inhibitory effect and rapid type: 1
    • inhibitory effect and replication viral infection: 1, 2, 3, 4, 5, 6
    • inhibitory effect and sensitive method: 1